research Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.
Search
for
Sort by
Research
840-870 / 1000+ resultsresearch Hispanismo europeo y teatro del Siglo de Oro español
Women with PCOS have a higher risk of severe COVID-19 due to related health issues.
research ACUTE TELOGEN EFFLUVIUM FOLLOWING SARS-COV-2 INFECTION: A RARE PEDIATRIC CASE
A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.
research Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts
Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.
research Pediatric alopecia areata following COVID ‐19 infection
Some children may develop hair loss after having COVID-19.
research Excessive hair loss as a complication after infection with SARS-CoV-2 virus
Some people lose a lot of hair after having COVID-19.
research The Possible Role of Antibodies in Alopecia: A Narrative Review
The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.
research Prevalence, Risk Factors, and Management Strategies of Alopecia in Saudi Arabia: A Systematic Review
Hair loss is common but often untreated in Saudi Arabia, needing more public awareness and better access to care.
research Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
COVID-19 may cause hair loss by affecting hair follicles.
research The Role of Vitamin D and Testosterone Levels with Hair Loss among Females with Coronavirus Disease
Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.
research Patients’ knowledge, attitude, and practice regarding alopecia: a cross-sectional study in Hebei, China
Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.
research Epidemiological Analysis of Alopecia in Migrant Communities at Dr. Hair™ Clinics
Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.
research Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
COVID-19-related hair loss may be linked to blood flow disorders and inflammation.
research The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).
research Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.
research Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.
research New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.
research How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
COVID-19 vaccination may lower vitamin D levels and cause hair loss.
research Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.
research Breaking bald: Unraveling the mysteries of hair loss and modern treatments
Hair loss has many causes and treatments, but future research aims for better solutions.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
research Telogen effluvium: a 360 degree review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.
research Review article in telogen effluvium
COVID-19 survivors working in healthcare may experience temporary hair loss.
research Hair loss is a symptom of many complex medical and psychological problems
Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.
research Editor's Picks August 2023
Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.
research Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research On the characterization of the effluvium following COVID ‐19 infection
Many people experience hair loss after COVID-19 infection.
research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.